Here is the latest stock price and chart of Indoco Remedies. For more details, see the Indoco Remedies company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
EXPIRES TOMORROW: Full Transcript of Our Urgent Broadcast on India's Revival
Live BSE Quotes | Apr 16, 2021 (Close) | ||
---|---|---|---|
Price (Rs)313.95 | Open (Rs) 311.25 | High (Rs) 317.75 | Low (Rs) 309.00 |
% Change2.10 | Volume 6,761 | Value (Rs) 2,127,986 | 52-Week H/L 335.55 / 190.00 |
Live NSE Quotes | Apr 16, 2021 (Close) | ||
---|---|---|---|
Price (Rs)313.85 | Open (Rs) 309.75 | High (Rs) 317.50 | Low (Rs) 309.15 |
% Change1.83 | Volume 149,797 | Value (Rs) 46,973,750 | 52-Week H/L 335.80 / 197.20 |
Change | |||||
---|---|---|---|---|---|
1 Day 2.10% | 1 Month 9.41% | 3 Months 0.79% | 1 Year 35.29% | 5 Years (CAGR)* 2.21% | 10 Years (CAGR)* 18.07% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 4.26 | P/E Ratio (x) 73.71 | Market Cap (Rs m) 28,938.34 | P/BV (x) 4.29 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
INDOCO REMEDIES last traded price was up 2.1% to Rs 314.0 on the BSE. On the NSE, INDOCO REMEDIES last traded price was up 1.8% to Rs 313.9. The total volume of shares traded was 0.2 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 1.9%. And the benchmark S&P BSE SENSEX was at 48,832.0 (up 0.1%).
Over the last 30 days, the INDOCO REMEDIES share price is up 5.7%. And over the last one year, INDOCO REMEDIES share price is up 30.0%.
What else is happening in the markets today? Dig in...
Indian share markets ended on a flat note on Friday. Benchmark indices gave up early gains during closing hours on Friday as investors worried about the surge in Covid cases in the country
For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.
For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More